Lipotes vexillifer (Yangtze River dolphin): 103070260
Help
Entry
103070260 CDS
T03090
Gene name
MAPK1
Definition
(RefSeq) mitogen-activated protein kinase 1
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
lve
Lipotes vexillifer (Yangtze River dolphin)
Pathway
lve01521
EGFR tyrosine kinase inhibitor resistance
lve01522
Endocrine resistance
lve01524
Platinum drug resistance
lve04010
MAPK signaling pathway
lve04012
ErbB signaling pathway
lve04014
Ras signaling pathway
lve04015
Rap1 signaling pathway
lve04022
cGMP-PKG signaling pathway
lve04024
cAMP signaling pathway
lve04062
Chemokine signaling pathway
lve04066
HIF-1 signaling pathway
lve04068
FoxO signaling pathway
lve04071
Sphingolipid signaling pathway
lve04072
Phospholipase D signaling pathway
lve04114
Oocyte meiosis
lve04140
Autophagy - animal
lve04150
mTOR signaling pathway
lve04151
PI3K-Akt signaling pathway
lve04210
Apoptosis
lve04218
Cellular senescence
lve04261
Adrenergic signaling in cardiomyocytes
lve04270
Vascular smooth muscle contraction
lve04350
TGF-beta signaling pathway
lve04360
Axon guidance
lve04370
VEGF signaling pathway
lve04371
Apelin signaling pathway
lve04380
Osteoclast differentiation
lve04510
Focal adhesion
lve04520
Adherens junction
lve04540
Gap junction
lve04550
Signaling pathways regulating pluripotency of stem cells
lve04611
Platelet activation
lve04620
Toll-like receptor signaling pathway
lve04621
NOD-like receptor signaling pathway
lve04625
C-type lectin receptor signaling pathway
lve04650
Natural killer cell mediated cytotoxicity
lve04657
IL-17 signaling pathway
lve04658
Th1 and Th2 cell differentiation
lve04659
Th17 cell differentiation
lve04660
T cell receptor signaling pathway
lve04662
B cell receptor signaling pathway
lve04664
Fc epsilon RI signaling pathway
lve04666
Fc gamma R-mediated phagocytosis
lve04668
TNF signaling pathway
lve04713
Circadian entrainment
lve04720
Long-term potentiation
lve04722
Neurotrophin signaling pathway
lve04723
Retrograde endocannabinoid signaling
lve04724
Glutamatergic synapse
lve04725
Cholinergic synapse
lve04726
Serotonergic synapse
lve04730
Long-term depression
lve04810
Regulation of actin cytoskeleton
lve04910
Insulin signaling pathway
lve04912
GnRH signaling pathway
lve04914
Progesterone-mediated oocyte maturation
lve04915
Estrogen signaling pathway
lve04916
Melanogenesis
lve04917
Prolactin signaling pathway
lve04919
Thyroid hormone signaling pathway
lve04921
Oxytocin signaling pathway
lve04926
Relaxin signaling pathway
lve04928
Parathyroid hormone synthesis, secretion and action
lve04929
GnRH secretion
lve04930
Type II diabetes mellitus
lve04933
AGE-RAGE signaling pathway in diabetic complications
lve04934
Cushing syndrome
lve04935
Growth hormone synthesis, secretion and action
lve04960
Aldosterone-regulated sodium reabsorption
lve05010
Alzheimer disease
lve05020
Prion disease
lve05022
Pathways of neurodegeneration - multiple diseases
lve05034
Alcoholism
lve05132
Salmonella infection
lve05133
Pertussis
lve05135
Yersinia infection
lve05140
Leishmaniasis
lve05142
Chagas disease
lve05145
Toxoplasmosis
lve05152
Tuberculosis
lve05160
Hepatitis C
lve05161
Hepatitis B
lve05163
Human cytomegalovirus infection
lve05164
Influenza A
lve05165
Human papillomavirus infection
lve05166
Human T-cell leukemia virus 1 infection
lve05167
Kaposi sarcoma-associated herpesvirus infection
lve05170
Human immunodeficiency virus 1 infection
lve05171
Coronavirus disease - COVID-19
lve05200
Pathways in cancer
lve05203
Viral carcinogenesis
lve05205
Proteoglycans in cancer
lve05206
MicroRNAs in cancer
lve05210
Colorectal cancer
lve05211
Renal cell carcinoma
lve05212
Pancreatic cancer
lve05213
Endometrial cancer
lve05214
Glioma
lve05215
Prostate cancer
lve05216
Thyroid cancer
lve05218
Melanoma
lve05219
Bladder cancer
lve05220
Chronic myeloid leukemia
lve05221
Acute myeloid leukemia
lve05223
Non-small cell lung cancer
lve05224
Breast cancer
lve05225
Hepatocellular carcinoma
lve05226
Gastric cancer
lve05230
Central carbon metabolism in cancer
lve05231
Choline metabolism in cancer
lve05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
KEGG Orthology (KO) [BR:
lve00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103070260 (MAPK1)
04012 ErbB signaling pathway
103070260 (MAPK1)
04014 Ras signaling pathway
103070260 (MAPK1)
04015 Rap1 signaling pathway
103070260 (MAPK1)
04350 TGF-beta signaling pathway
103070260 (MAPK1)
04370 VEGF signaling pathway
103070260 (MAPK1)
04371 Apelin signaling pathway
103070260 (MAPK1)
04668 TNF signaling pathway
103070260 (MAPK1)
04066 HIF-1 signaling pathway
103070260 (MAPK1)
04068 FoxO signaling pathway
103070260 (MAPK1)
04072 Phospholipase D signaling pathway
103070260 (MAPK1)
04071 Sphingolipid signaling pathway
103070260 (MAPK1)
04024 cAMP signaling pathway
103070260 (MAPK1)
04022 cGMP-PKG signaling pathway
103070260 (MAPK1)
04151 PI3K-Akt signaling pathway
103070260 (MAPK1)
04150 mTOR signaling pathway
103070260 (MAPK1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
103070260 (MAPK1)
09143 Cell growth and death
04114 Oocyte meiosis
103070260 (MAPK1)
04210 Apoptosis
103070260 (MAPK1)
04218 Cellular senescence
103070260 (MAPK1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
103070260 (MAPK1)
04520 Adherens junction
103070260 (MAPK1)
04540 Gap junction
103070260 (MAPK1)
04550 Signaling pathways regulating pluripotency of stem cells
103070260 (MAPK1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
103070260 (MAPK1)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
103070260 (MAPK1)
04620 Toll-like receptor signaling pathway
103070260 (MAPK1)
04621 NOD-like receptor signaling pathway
103070260 (MAPK1)
04625 C-type lectin receptor signaling pathway
103070260 (MAPK1)
04650 Natural killer cell mediated cytotoxicity
103070260 (MAPK1)
04660 T cell receptor signaling pathway
103070260 (MAPK1)
04658 Th1 and Th2 cell differentiation
103070260 (MAPK1)
04659 Th17 cell differentiation
103070260 (MAPK1)
04657 IL-17 signaling pathway
103070260 (MAPK1)
04662 B cell receptor signaling pathway
103070260 (MAPK1)
04664 Fc epsilon RI signaling pathway
103070260 (MAPK1)
04666 Fc gamma R-mediated phagocytosis
103070260 (MAPK1)
04062 Chemokine signaling pathway
103070260 (MAPK1)
09152 Endocrine system
04910 Insulin signaling pathway
103070260 (MAPK1)
04929 GnRH secretion
103070260 (MAPK1)
04912 GnRH signaling pathway
103070260 (MAPK1)
04915 Estrogen signaling pathway
103070260 (MAPK1)
04914 Progesterone-mediated oocyte maturation
103070260 (MAPK1)
04917 Prolactin signaling pathway
103070260 (MAPK1)
04921 Oxytocin signaling pathway
103070260 (MAPK1)
04926 Relaxin signaling pathway
103070260 (MAPK1)
04935 Growth hormone synthesis, secretion and action
103070260 (MAPK1)
04919 Thyroid hormone signaling pathway
103070260 (MAPK1)
04928 Parathyroid hormone synthesis, secretion and action
103070260 (MAPK1)
04916 Melanogenesis
103070260 (MAPK1)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
103070260 (MAPK1)
04270 Vascular smooth muscle contraction
103070260 (MAPK1)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
103070260 (MAPK1)
09156 Nervous system
04724 Glutamatergic synapse
103070260 (MAPK1)
04725 Cholinergic synapse
103070260 (MAPK1)
04726 Serotonergic synapse
103070260 (MAPK1)
04720 Long-term potentiation
103070260 (MAPK1)
04730 Long-term depression
103070260 (MAPK1)
04723 Retrograde endocannabinoid signaling
103070260 (MAPK1)
04722 Neurotrophin signaling pathway
103070260 (MAPK1)
09158 Development and regeneration
04360 Axon guidance
103070260 (MAPK1)
04380 Osteoclast differentiation
103070260 (MAPK1)
09159 Environmental adaptation
04713 Circadian entrainment
103070260 (MAPK1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103070260 (MAPK1)
05206 MicroRNAs in cancer
103070260 (MAPK1)
05205 Proteoglycans in cancer
103070260 (MAPK1)
05203 Viral carcinogenesis
103070260 (MAPK1)
05230 Central carbon metabolism in cancer
103070260 (MAPK1)
05231 Choline metabolism in cancer
103070260 (MAPK1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
103070260 (MAPK1)
09162 Cancer: specific types
05210 Colorectal cancer
103070260 (MAPK1)
05212 Pancreatic cancer
103070260 (MAPK1)
05225 Hepatocellular carcinoma
103070260 (MAPK1)
05226 Gastric cancer
103070260 (MAPK1)
05214 Glioma
103070260 (MAPK1)
05216 Thyroid cancer
103070260 (MAPK1)
05221 Acute myeloid leukemia
103070260 (MAPK1)
05220 Chronic myeloid leukemia
103070260 (MAPK1)
05218 Melanoma
103070260 (MAPK1)
05211 Renal cell carcinoma
103070260 (MAPK1)
05219 Bladder cancer
103070260 (MAPK1)
05215 Prostate cancer
103070260 (MAPK1)
05213 Endometrial cancer
103070260 (MAPK1)
05224 Breast cancer
103070260 (MAPK1)
05223 Non-small cell lung cancer
103070260 (MAPK1)
09164 Neurodegenerative disease
05010 Alzheimer disease
103070260 (MAPK1)
05020 Prion disease
103070260 (MAPK1)
05022 Pathways of neurodegeneration - multiple diseases
103070260 (MAPK1)
09165 Substance dependence
05034 Alcoholism
103070260 (MAPK1)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
103070260 (MAPK1)
04933 AGE-RAGE signaling pathway in diabetic complications
103070260 (MAPK1)
04934 Cushing syndrome
103070260 (MAPK1)
09171 Infectious disease: bacterial
05132 Salmonella infection
103070260 (MAPK1)
05135 Yersinia infection
103070260 (MAPK1)
05133 Pertussis
103070260 (MAPK1)
05152 Tuberculosis
103070260 (MAPK1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
103070260 (MAPK1)
05170 Human immunodeficiency virus 1 infection
103070260 (MAPK1)
05161 Hepatitis B
103070260 (MAPK1)
05160 Hepatitis C
103070260 (MAPK1)
05171 Coronavirus disease - COVID-19
103070260 (MAPK1)
05164 Influenza A
103070260 (MAPK1)
05163 Human cytomegalovirus infection
103070260 (MAPK1)
05167 Kaposi sarcoma-associated herpesvirus infection
103070260 (MAPK1)
05165 Human papillomavirus infection
103070260 (MAPK1)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
103070260 (MAPK1)
05140 Leishmaniasis
103070260 (MAPK1)
05142 Chagas disease
103070260 (MAPK1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
103070260 (MAPK1)
01524 Platinum drug resistance
103070260 (MAPK1)
01522 Endocrine resistance
103070260 (MAPK1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
lve01001
]
103070260 (MAPK1)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
lve03036
]
103070260 (MAPK1)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
lve04147
]
103070260 (MAPK1)
Enzymes [BR:
lve01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
103070260 (MAPK1)
Protein kinases [BR:
lve01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
103070260 (MAPK1)
Chromosome and associated proteins [BR:
lve03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
103070260 (MAPK1)
Exosome [BR:
lve04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
103070260 (MAPK1)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
APH
Choline_kinase
FTA2
Kdo
Kinase-like
Motif
Other DBs
NCBI-GeneID:
103070260
NCBI-ProteinID:
XP_007451077
UniProt:
A0A340WNH5
LinkDB
All DBs
Position
Un
AA seq
263 aa
AA seq
DB search
MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL
NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI
LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR
LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDD
LPKEKLKELIFEETARFQPGYRS
NT seq
792 nt
NT seq
+upstream
nt +downstream
nt
atgaaagatgtatatatagtacaggacctcatggaaacagatctctacaagctcttgaag
acgcaacacctcagcaatgaccatatctgctattttctttaccagatcctcagagggtta
aaatatatccattcagctaacgtgctgcaccgtgacctcaaaccttccaacctgctgctc
aacaccacctgcgatctcaagatctgtgactttggcttggcccgtgttgcagatccagac
catgatcacacagggttcctgacggagtacgttgccacacgttggtacagggctccggaa
attatgttgaattccaagggctacaccaagtccattgatatttggtctgtaggctgcatc
ctggcagagatgctctccaacaggcccatcttcccggggaagcattacctcgaccagctg
aaccacattctgggtattcttggatccccatcccaggaagacctgaattgtataataaat
ttaaaagctagaaactatttgctttctcttccgcacaaaaataaggtgccatggaacagg
ctgttcccaaatgctgactccaaagctctagatttactggacaagatgttgacgttcaac
cctcataagaggattgaggtggaacaggctctggcccacccatacctggagcagtactac
gacccaagtgacgagcccatcgccgaagcaccgttcaagtttgacatggaattggatgac
ttgcccaaggaaaagctcaaagaactcatttttgaagagaccgctagattccagccagga
tacagatcttaa
Lipotes vexillifer (Yangtze River dolphin): 103075543
Help
Entry
103075543 CDS
T03090
Gene name
MAPK3
Definition
(RefSeq) mitogen-activated protein kinase 3
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
lve
Lipotes vexillifer (Yangtze River dolphin)
Pathway
lve01521
EGFR tyrosine kinase inhibitor resistance
lve01522
Endocrine resistance
lve01524
Platinum drug resistance
lve04010
MAPK signaling pathway
lve04012
ErbB signaling pathway
lve04014
Ras signaling pathway
lve04015
Rap1 signaling pathway
lve04022
cGMP-PKG signaling pathway
lve04024
cAMP signaling pathway
lve04062
Chemokine signaling pathway
lve04066
HIF-1 signaling pathway
lve04068
FoxO signaling pathway
lve04071
Sphingolipid signaling pathway
lve04072
Phospholipase D signaling pathway
lve04114
Oocyte meiosis
lve04140
Autophagy - animal
lve04150
mTOR signaling pathway
lve04151
PI3K-Akt signaling pathway
lve04210
Apoptosis
lve04218
Cellular senescence
lve04261
Adrenergic signaling in cardiomyocytes
lve04270
Vascular smooth muscle contraction
lve04350
TGF-beta signaling pathway
lve04360
Axon guidance
lve04370
VEGF signaling pathway
lve04371
Apelin signaling pathway
lve04380
Osteoclast differentiation
lve04510
Focal adhesion
lve04520
Adherens junction
lve04540
Gap junction
lve04550
Signaling pathways regulating pluripotency of stem cells
lve04611
Platelet activation
lve04620
Toll-like receptor signaling pathway
lve04621
NOD-like receptor signaling pathway
lve04625
C-type lectin receptor signaling pathway
lve04650
Natural killer cell mediated cytotoxicity
lve04657
IL-17 signaling pathway
lve04658
Th1 and Th2 cell differentiation
lve04659
Th17 cell differentiation
lve04660
T cell receptor signaling pathway
lve04662
B cell receptor signaling pathway
lve04664
Fc epsilon RI signaling pathway
lve04666
Fc gamma R-mediated phagocytosis
lve04668
TNF signaling pathway
lve04713
Circadian entrainment
lve04720
Long-term potentiation
lve04722
Neurotrophin signaling pathway
lve04723
Retrograde endocannabinoid signaling
lve04724
Glutamatergic synapse
lve04725
Cholinergic synapse
lve04726
Serotonergic synapse
lve04730
Long-term depression
lve04810
Regulation of actin cytoskeleton
lve04910
Insulin signaling pathway
lve04912
GnRH signaling pathway
lve04914
Progesterone-mediated oocyte maturation
lve04915
Estrogen signaling pathway
lve04916
Melanogenesis
lve04917
Prolactin signaling pathway
lve04919
Thyroid hormone signaling pathway
lve04921
Oxytocin signaling pathway
lve04926
Relaxin signaling pathway
lve04928
Parathyroid hormone synthesis, secretion and action
lve04929
GnRH secretion
lve04930
Type II diabetes mellitus
lve04933
AGE-RAGE signaling pathway in diabetic complications
lve04934
Cushing syndrome
lve04935
Growth hormone synthesis, secretion and action
lve04960
Aldosterone-regulated sodium reabsorption
lve05010
Alzheimer disease
lve05020
Prion disease
lve05022
Pathways of neurodegeneration - multiple diseases
lve05034
Alcoholism
lve05132
Salmonella infection
lve05133
Pertussis
lve05135
Yersinia infection
lve05140
Leishmaniasis
lve05142
Chagas disease
lve05145
Toxoplasmosis
lve05152
Tuberculosis
lve05160
Hepatitis C
lve05161
Hepatitis B
lve05163
Human cytomegalovirus infection
lve05164
Influenza A
lve05165
Human papillomavirus infection
lve05166
Human T-cell leukemia virus 1 infection
lve05167
Kaposi sarcoma-associated herpesvirus infection
lve05170
Human immunodeficiency virus 1 infection
lve05171
Coronavirus disease - COVID-19
lve05200
Pathways in cancer
lve05203
Viral carcinogenesis
lve05205
Proteoglycans in cancer
lve05206
MicroRNAs in cancer
lve05210
Colorectal cancer
lve05211
Renal cell carcinoma
lve05212
Pancreatic cancer
lve05213
Endometrial cancer
lve05214
Glioma
lve05215
Prostate cancer
lve05216
Thyroid cancer
lve05218
Melanoma
lve05219
Bladder cancer
lve05220
Chronic myeloid leukemia
lve05221
Acute myeloid leukemia
lve05223
Non-small cell lung cancer
lve05224
Breast cancer
lve05225
Hepatocellular carcinoma
lve05226
Gastric cancer
lve05230
Central carbon metabolism in cancer
lve05231
Choline metabolism in cancer
lve05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Brite
KEGG Orthology (KO) [BR:
lve00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
103075543 (MAPK3)
04012 ErbB signaling pathway
103075543 (MAPK3)
04014 Ras signaling pathway
103075543 (MAPK3)
04015 Rap1 signaling pathway
103075543 (MAPK3)
04350 TGF-beta signaling pathway
103075543 (MAPK3)
04370 VEGF signaling pathway
103075543 (MAPK3)
04371 Apelin signaling pathway
103075543 (MAPK3)
04668 TNF signaling pathway
103075543 (MAPK3)
04066 HIF-1 signaling pathway
103075543 (MAPK3)
04068 FoxO signaling pathway
103075543 (MAPK3)
04072 Phospholipase D signaling pathway
103075543 (MAPK3)
04071 Sphingolipid signaling pathway
103075543 (MAPK3)
04024 cAMP signaling pathway
103075543 (MAPK3)
04022 cGMP-PKG signaling pathway
103075543 (MAPK3)
04151 PI3K-Akt signaling pathway
103075543 (MAPK3)
04150 mTOR signaling pathway
103075543 (MAPK3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
103075543 (MAPK3)
09143 Cell growth and death
04114 Oocyte meiosis
103075543 (MAPK3)
04210 Apoptosis
103075543 (MAPK3)
04218 Cellular senescence
103075543 (MAPK3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
103075543 (MAPK3)
04520 Adherens junction
103075543 (MAPK3)
04540 Gap junction
103075543 (MAPK3)
04550 Signaling pathways regulating pluripotency of stem cells
103075543 (MAPK3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
103075543 (MAPK3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
103075543 (MAPK3)
04620 Toll-like receptor signaling pathway
103075543 (MAPK3)
04621 NOD-like receptor signaling pathway
103075543 (MAPK3)
04625 C-type lectin receptor signaling pathway
103075543 (MAPK3)
04650 Natural killer cell mediated cytotoxicity
103075543 (MAPK3)
04660 T cell receptor signaling pathway
103075543 (MAPK3)
04658 Th1 and Th2 cell differentiation
103075543 (MAPK3)
04659 Th17 cell differentiation
103075543 (MAPK3)
04657 IL-17 signaling pathway
103075543 (MAPK3)
04662 B cell receptor signaling pathway
103075543 (MAPK3)
04664 Fc epsilon RI signaling pathway
103075543 (MAPK3)
04666 Fc gamma R-mediated phagocytosis
103075543 (MAPK3)
04062 Chemokine signaling pathway
103075543 (MAPK3)
09152 Endocrine system
04910 Insulin signaling pathway
103075543 (MAPK3)
04929 GnRH secretion
103075543 (MAPK3)
04912 GnRH signaling pathway
103075543 (MAPK3)
04915 Estrogen signaling pathway
103075543 (MAPK3)
04914 Progesterone-mediated oocyte maturation
103075543 (MAPK3)
04917 Prolactin signaling pathway
103075543 (MAPK3)
04921 Oxytocin signaling pathway
103075543 (MAPK3)
04926 Relaxin signaling pathway
103075543 (MAPK3)
04935 Growth hormone synthesis, secretion and action
103075543 (MAPK3)
04919 Thyroid hormone signaling pathway
103075543 (MAPK3)
04928 Parathyroid hormone synthesis, secretion and action
103075543 (MAPK3)
04916 Melanogenesis
103075543 (MAPK3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
103075543 (MAPK3)
04270 Vascular smooth muscle contraction
103075543 (MAPK3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
103075543 (MAPK3)
09156 Nervous system
04724 Glutamatergic synapse
103075543 (MAPK3)
04725 Cholinergic synapse
103075543 (MAPK3)
04726 Serotonergic synapse
103075543 (MAPK3)
04720 Long-term potentiation
103075543 (MAPK3)
04730 Long-term depression
103075543 (MAPK3)
04723 Retrograde endocannabinoid signaling
103075543 (MAPK3)
04722 Neurotrophin signaling pathway
103075543 (MAPK3)
09158 Development and regeneration
04360 Axon guidance
103075543 (MAPK3)
04380 Osteoclast differentiation
103075543 (MAPK3)
09159 Environmental adaptation
04713 Circadian entrainment
103075543 (MAPK3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
103075543 (MAPK3)
05206 MicroRNAs in cancer
103075543 (MAPK3)
05205 Proteoglycans in cancer
103075543 (MAPK3)
05203 Viral carcinogenesis
103075543 (MAPK3)
05230 Central carbon metabolism in cancer
103075543 (MAPK3)
05231 Choline metabolism in cancer
103075543 (MAPK3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
103075543 (MAPK3)
09162 Cancer: specific types
05210 Colorectal cancer
103075543 (MAPK3)
05212 Pancreatic cancer
103075543 (MAPK3)
05225 Hepatocellular carcinoma
103075543 (MAPK3)
05226 Gastric cancer
103075543 (MAPK3)
05214 Glioma
103075543 (MAPK3)
05216 Thyroid cancer
103075543 (MAPK3)
05221 Acute myeloid leukemia
103075543 (MAPK3)
05220 Chronic myeloid leukemia
103075543 (MAPK3)
05218 Melanoma
103075543 (MAPK3)
05211 Renal cell carcinoma
103075543 (MAPK3)
05219 Bladder cancer
103075543 (MAPK3)
05215 Prostate cancer
103075543 (MAPK3)
05213 Endometrial cancer
103075543 (MAPK3)
05224 Breast cancer
103075543 (MAPK3)
05223 Non-small cell lung cancer
103075543 (MAPK3)
09164 Neurodegenerative disease
05010 Alzheimer disease
103075543 (MAPK3)
05020 Prion disease
103075543 (MAPK3)
05022 Pathways of neurodegeneration - multiple diseases
103075543 (MAPK3)
09165 Substance dependence
05034 Alcoholism
103075543 (MAPK3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
103075543 (MAPK3)
04933 AGE-RAGE signaling pathway in diabetic complications
103075543 (MAPK3)
04934 Cushing syndrome
103075543 (MAPK3)
09171 Infectious disease: bacterial
05132 Salmonella infection
103075543 (MAPK3)
05135 Yersinia infection
103075543 (MAPK3)
05133 Pertussis
103075543 (MAPK3)
05152 Tuberculosis
103075543 (MAPK3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
103075543 (MAPK3)
05170 Human immunodeficiency virus 1 infection
103075543 (MAPK3)
05161 Hepatitis B
103075543 (MAPK3)
05160 Hepatitis C
103075543 (MAPK3)
05171 Coronavirus disease - COVID-19
103075543 (MAPK3)
05164 Influenza A
103075543 (MAPK3)
05163 Human cytomegalovirus infection
103075543 (MAPK3)
05167 Kaposi sarcoma-associated herpesvirus infection
103075543 (MAPK3)
05165 Human papillomavirus infection
103075543 (MAPK3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
103075543 (MAPK3)
05140 Leishmaniasis
103075543 (MAPK3)
05142 Chagas disease
103075543 (MAPK3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
103075543 (MAPK3)
01524 Platinum drug resistance
103075543 (MAPK3)
01522 Endocrine resistance
103075543 (MAPK3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
lve01001
]
103075543 (MAPK3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
lve03036
]
103075543 (MAPK3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
lve04147
]
103075543 (MAPK3)
Enzymes [BR:
lve01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
103075543 (MAPK3)
Protein kinases [BR:
lve01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
103075543 (MAPK3)
Chromosome and associated proteins [BR:
lve03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
103075543 (MAPK3)
Exosome [BR:
lve04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
103075543 (MAPK3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
APH
Choline_kinase
FTA2
Kdo
NDUF_B4
Pkinase_fungal
Motif
Other DBs
NCBI-GeneID:
103075543
NCBI-ProteinID:
XP_007452842
UniProt:
A0A340WYU9
LinkDB
All DBs
Position
Un
AA seq
325 aa
AA seq
DB search
MVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAPTLEA
MRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLI
NTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI
LAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAK
LFPKSDPKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFDMELDD
LPKERLKELIFQETARFQPGVLEAP
NT seq
978 nt
NT seq
+upstream
nt +downstream
nt
atggtcagctcagcttacgaccatgtgcgcaagactcgagtggccatcaagaaaatcagc
ccctttgagcatcagacctactgccagcgtacgttgcgagagatccagatcttgctgcgc
ttccgccatgagaacgtcatcggcatccgagacattctgcgggcacccaccctggaagcc
atgagggatgtctacattgtgcaagacctgatggagacagacctgtacaagttgcttaaa
agccagcagctgagcaacgaccacatctgctacttcctctaccaaatcctgcggggcctc
aagtatatccattctgccaacgtgctccaccgggatttaaagccctccaacctgctcatc
aacaccacctgcgaccttaagatctgtgattttggtcttgcccggattgccgatcctgag
cacgaccacactggctttctgacggaatacgtggccacacgctggtaccgggccccagag
atcatgcttaactccaagggctacaccaagtccatcgacatctggtctgtgggctgcatt
ctggctgagatgctctccaaccggcccatcttcccgggcaagcactacctggaccagctc
aaccacattctgggtatcctgggctccccctcccaggaggacctgaattgtatcatcaac
atgaaggcccgaaactacctacagtctctaccctccaagaccaaggtggcctgggccaag
ctttttcccaagtcggaccccaaagctcttgacctgctggaccggatgttgacctttaac
cccaacaaacggatcacagtggaagaagcactggctcacccctacctggaacagtactac
gacccaacagatgagccagtggccgaggaacctttcaccttcgacatggagctggatgat
ctacccaaggagcggctgaaggagctcatcttccaggagacagcccgtttccagcctggg
gtgctggaggccccctaa
DBGET
integrated database retrieval system